Get Started Free
Home›Healthcare›Thermo Fisher Scientific
Thermo Fisher Scientific logo
Thermo Fisher Scientific
Healthcare

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific logo

Thermo Fisher Scientific

● Active
Healthcare · Waltham, MA · Est. 1956
Life SciencesDiagnosticsBioprocessingInstrumentationHealthcare↗ Website
$195B
Valuation
$44.9B
Revenue
130k+
Employees
1956
Founded

Thermo Fisher Scientific is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services for scientific research, bioprocessing, clinical diagnostics, and pharmaceutical manufacturing. With over $44B in annual revenue, Thermo Fisher serves pharmaceutical and biotech companies, academic research institutions, clinical laboratories, and government agencies with an unmatched portfolio spanning mass spectrometry, chromatography, cell culture, genetic analysis, and laboratory equipment.

Recent Press
5 items
Award·2026-02-03
Thermo Fisher Named to Fortune Most Admired Companies List for 10th Consecutive Year
Thermo Fisher Scientific was recognized on Fortune's World's Most Admired Companies list for the tenth consecutive year, ranking #1 in the Medical Products & Equipment sector for innovation, quality of management, and use of corporate assets.
Press Release·2026-01-29
Thermo Fisher Scientific Reports Full Year 2025 Revenue of $44.9B
Thermo Fisher reported FY2025 revenue of $44.9B, up 5% year-over-year, with strong performance in its Life Sciences Solutions and Analytical Instruments segments recovering from the 2023-2024 biotech funding downturn, and continued growth in pharma services.
Partnership·2026-01-12
Thermo Fisher Scientific Announces Strategic Collaboration with NVIDIA to Advance AI-Driven Laboratory Automation
Announced at the J.P. Morgan Healthcare Conference, the NVIDIA collaboration will embed AI into Thermo Fisher's scientific instruments and lab infrastructure to increase automation accuracy and speed across research workflows.
Acquisition·2025-10-29
Thermo Fisher Scientific to Acquire Clario Holdings for $8.875 Billion
Thermo Fisher announced a definitive agreement to acquire Clario Holdings for $8.875B in cash, adding clinical endpoint technology and data capabilities to accelerate pharma and biotech customers' clinical trials.
Partnership·2025-10-16
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
Thermo Fisher and OpenAI announced a strategic collaboration to apply AI across drug development and clinical trials, aiming to compress research timelines and accelerate delivery of new medicines to patients.
Company History
9 milestones
George Hatsopoulos founded Thermo Electron Corporation in 1956 in Waltham, Massachusetts, initially focused on thermionic energy conversion devices. The company grew into a diversified scientific instruments and energy company through the 1970s–1990s.

Thermo Fisher Scientific Organization Structure & Team

Org Chart
130,000 employees · Click a leader to explore their team
104,600 across 12 departments
Chief Executive Officer
Marc Casper
Stephen Williamson — Departments
· 104600 people across 12 depts

Thermo Fisher Scientific Financials, Revenue & Market Share

Annual Revenue
$44.9B
+5% vs prior year
YoY Growth
+5%
From $39.2B to $44.9B
Revenue / Employee
$345K
Annual revenue per full-time employee
Revenue Growth
2021
2022
2023
2024
2025
$39.2B
$44.9B
$42.9B
$42.9B
$44.9B
Market Share
Global Life Sciences Tools & Services
28%
share
Thermo Fisher Scientific
28%
Danaher / Cytiva
14%
Agilent Technologies
5%
Waters Corporation
3%
Sartorius
4%
$320B
TAM
$180B
SAM
$44.9B
SOM
Revenue Streams
Life Sciences Solutions32%
Analytical Instruments22%
Laboratory Products & Biopharma Services32%
Specialty Diagnostics14%
Business Units
Life Sciences Solutions (LSS)32%
Discovery biology reagents, Gibco cell culture, PCR/qPCR consumables, protein biology kits, flow cytometry — serving pharma R&D, academic research, and biopharmaceutical upstream bioprocessing.
Analytical Instruments (AI)22%
Orbitrap MS, Vanquish UHPLC, ICP-MS, electron microscopy, FTIR — serving pharmaceutical QC, environmental testing, materials science, and food safety analytical labs.
Laboratory Products & Biopharma Services (LPBS)32%
Fisher Scientific lab distribution, CDMO/Pharma Services, clinical research (PPD), and laboratory services — the largest revenue segment by size.
Specialty Diagnostics (SD)14%
Clinical immunoassay, transplant diagnostics, allergy/autoimmune testing, and rapid POC diagnostics — serving hospitals and reference labs in regulated clinical markets.

Thermo Fisher Scientific Internal Tools & Processes

Internal Tools
12 departments
Mass Spectrometry & Chromatography R&D4200 people · 3 roles
Standards & Certifications
10 standards
Compliance frameworks, security audits, and quality certifications this company maintains.
Quality
ISO 9001:2015
Certified
Thermo Fisher's global manufacturing sites — spanning Waltham MA, Asheville NC, Lenexa KS, Paisley UK, and Singapore — are ISO 9001:2015 certified, ensuring that instrument design, reagent manufacturing, and service delivery meet international quality standards expected by pharmaceutical, clinical, and industrial laboratory customers.
Quality
ISO 13485
Certified
Thermo Fisher's Specialty Diagnostics and Applied Biosystems divisions hold ISO 13485 certification for medical device quality management, covering in vitro diagnostic reagents, clinical immunoassay kits, and companion diagnostic NGS assays — required for CE-IVD marking and FDA 510(k) submissions.
Regulatory
21 CFR Part 11
Compliant
Thermo Fisher's Chromeleon CDS, Xcalibur, and Thermo Scientific SampleManager LIMS platforms are designed for 21 CFR Part 11 compliance, enabling pharmaceutical customers to use Thermo Fisher software systems in GMP-regulated analytical and manufacturing environments with audit trails, electronic signatures, and data integrity controls.
Regulatory
cGMP (21 CFR Parts 210/211)
Compliant
Thermo Fisher's Pharma Services Group (Patheon CDMO) operates its drug substance and drug product manufacturing facilities under FDA current Good Manufacturing Practice (cGMP) regulations per 21 CFR Parts 210 and 211, supporting pharmaceutical customers in producing clinical and commercial biologic and small molecule medicines.
Environmental
ISO 14001:2015
Certified
Thermo Fisher operates under ISO 14001:2015 environmental management certification across major manufacturing and distribution operations, supporting its Science for Sustainability commitments to reduce Scope 1 and 2 greenhouse gas emissions 50% by 2030 and achieve net-zero operations by 2050.
Security
SOC 2 Type II
Certified
Thermo Fisher's cloud-hosted SampleManager LIMS, Thermo Fisher Connect, and ScienceCloud platforms are audited under SOC 2 Type II, providing pharmaceutical and clinical laboratory customers with independent assurance of data security, availability, and confidentiality controls for cloud-based laboratory data management.
Regulatory
ITAR / EAR
Compliant
Thermo Fisher maintains an export compliance program covering ITAR and EAR regulations for controlled dual-use instruments including electron microscopes, mass spectrometers, and ion beam systems that may require export licenses for controlled-country sales, ensuring compliance across 150+ country distribution footprint.
Regulatory
CLIA
Compliant
Thermo Fisher's clinical diagnostics products — including transplant diagnostics, allergy immunoassay kits, and Ion Torrent Genexus companion diagnostics — are designed to support customer compliance with CLIA requirements for diagnostic accuracy, precision, and quality control in accredited clinical laboratory environments.
Regulatory
ICH Q10 Pharmaceutical Quality
Compliant
Thermo Fisher's Pharma Services Group CDMO operations and instrument portfolio support customer ICH Q10 pharmaceutical quality system implementation, with manufacturing procedures, deviation management, and CAPA systems aligned to ICH Q10 expectations for process performance and product quality monitoring.
Environmental
RoHS / REACH
Compliant
All Thermo Fisher instruments and reagents sold in the European Union comply with RoHS restrictions on hazardous substances and REACH chemical substance registration requirements, with substance declaration processes managed through Thermo Fisher's global product compliance program.

Thermo Fisher Scientific Interview Preparation

Interview Prep
Role-specific interview questions and keywords. Select a department, then click any role to prepare.
Mass Spectrometry & Chromatography R&D· 3 roles

Thermo Fisher Scientific Products & Competitors

Product Suite
5 products · select one to explore
Healthcare
Analytics
Thermo Fisher Orbitrap Astral Mass Spectrometer
Redefining proteomics speed and depth

The Thermo Fisher Orbitrap Astral is a next-generation high-resolution accurate mass spectrometer designed for single-cell proteomics, plasma proteomics, and high-throughput drug discovery applications, achieving 200 samples/day throughput with sub-ppm mass accuracy. Its Orbitrap Astral mass analyzer combines ultra-fast data acquisition with the signature Orbitrap resolving power that has defined proteomics research since 2005.

Use Cases
Profiling the full plasma proteome depth of 5,000+ proteins from 4 µL of blood in a single 20-minute LC/MS run for biomarker discoveryRunning single-cell proteomics experiments quantifying 1,000+ proteins per cell using Thermo Fisher Single Cell ProtEomics (SCoPE-MS) workflowsPerforming high-throughput drug target occupancy and proteome-wide selectivity profiling for kinase inhibitor programs in pharmaceutical lead optimization
No image
Key Customers
GENE
Genentech
AZN
AstraZeneca
BROAD
Broad Institute
Competitive Intelligence
VSBruker timsTOF Ultra
THEM

Bruker's timsTOF Ultra is a trapped ion mobility mass spectrometer that combines PASEF fragmentation with 4D-omics data acquisition, delivering industry-leading single-cell sensitivity and ion mobility CCS information for proteomics and lipidomics research at throughputs competitive with Orbitrap systems.

EDGE

Superior Orbitrap mass accuracy (<1 ppm) and 20-year data legacy with established MaxQuant and Proteome Discoverer bioinformatics ecosystem

VSAgilent 6560 IM-QTOF
THEM

The Agilent 6560 Ion Mobility Q-TOF is a high-resolution quadrupole time-of-flight mass spectrometer with traveling wave ion mobility for structural proteomics, lipidomics, and glycomics — targeting research labs that need CCS database matching alongside accurate mass.

EDGE

The Orbitrap Astral is specifically optimized for proteomics throughput with 200 samples/day compared to QTOF architectures designed for broader omics flexibility

VSWaters SELECT SERIES MRT
THEM

Waters SELECT SERIES Multi-Reflecting Time-of-Flight is an ultra-high-resolution MS platform using a folded flight path to achieve >100,000 FWHM resolution for intact protein and metabolomics research, competing with Orbitrap in high-resolution metabolomics workflows.

EDGE

Orbitrap Astral's data-independent acquisition (DIA) speed advantage enables proteome-wide coverage at throughputs unmatched by reflectron TOF architectures

Related Companies

Eli Lilly logo
Eli Lilly
Healthcare
Eli Lilly is a global pharmaceutical company that discovers, develops, and markets medicines across diabetes, oncology, immunology, and neuroscience. Its GLP-1 receptor agonist portfolio — Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity — drove record revenue growth and positioned Lilly as one of the world's most valuable pharmaceutical companies.
Agilent Technologies logo
Agilent Technologies
Healthcare
Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical analysis, providing instruments, software, services, and consumables for laboratories worldwide. Its customers include pharmaceutical companies, academic research institutions, environmental labs, and food safety organizations that rely on Agilent's measurement science for analysis, testing, and compliance workflows.
Abbott Laboratories logo
Abbott Laboratories
Healthcare
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. Its portfolio spans the FreeStyle Libre continuous glucose monitoring system — the world's most-used CGM — alongside cardiac devices, point-of-care diagnostics, and infant nutrition brands across 160 countries.
Medtronic logo
Medtronic
Healthcare
Medtronic is the world's largest standalone medical device company, developing therapies and diagnostics across cardiac rhythm management, surgical robotics, neuromodulation, diabetes technology, and endoscopy. Its portfolio spans implantable cardiac monitors, transcatheter pacemakers, robotic surgery platforms, and closed-loop insulin delivery systems used in over 150 countries.
Stryker Corporation logo
Stryker Corporation
Healthcare
Stryker is one of the world's leading medical technology companies, offering a broad portfolio of innovative products and services in orthopedics, medical and surgical equipment, and neurotechnology. The company serves surgeons, hospitals, and healthcare systems across 75 countries with products ranging from joint replacement implants and surgical robots to emergency medical equipment.
Johnson & Johnson logo
Johnson & Johnson
Healthcare
Johnson & Johnson is one of the world's largest healthcare companies, operating across two segments — Innovative Medicine, which develops and markets prescription pharmaceuticals for oncology, immunology, neuroscience, and cardiovascular diseases, and MedTech, which produces surgical robotics, orthopedics, cardiovascular devices, and vision care products. After spinning off its consumer health division as Kenvue in 2023, J&J focuses exclusively on innovative medicine and medical technology.